Company
Tissue Regenix Group PLC
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 12 of 13
Archive
Proactive news summary: Abzena PLC, Breedon Aggregates Ltd, Noricum Gold Ltd and more...
Metal Tiger chairman Terry buys £50,000 worth of shares in the AIM listed resources investor, news from Horse Hill and an update of Abzena's acquisitions.
Tissue Regenix PLC granted US clearance for hernia implant
It is the first time an implant using Tissue’s cell washing technology has been approved by the US Food and Drug Administration.
Archive
Proactive news summary: Metal Tiger, Ariana Resources, Solo Oil, DP Poland and more
A pivotal day for mining investor Metal Tiger, "rapid progress" for Ariana Resources and a new director at Oilex.
Tissue Regenix adds sales specialist for US orthopaedic drive
Distin is a specialist in building sales through targeted marketing and has worked for a number of other US companies.
Tissue Regenix to display nine posters at US woundcare conference
The posters were written by opinion leaders in the field and selected by a peer review committee.
Archive
Proactive news highlights - Union Jack Oil, Arian Silver, Metals Exploration and DiamondCorp
Junior mining stocks featured prominently on Tuesday
Tissue Regenix to market heart valves through German venture
It is the first commercial application of the cell washing technology, dCELL, in heart valves.
Archive
Proactive news highlights - Tissue Regenix, Kromek and Collagen Solutions
Medical technology and pharma firms stepped forward today. Woundcare specialist Tissue Regenix saw shares rise over 9%...
Risers & Fallers: WH Smth, Pets At Home, Shell, Biofrontera...
Major share price risers and fallers today at 4.15pm
Tissue Regenix bolsters board with Consort chief
Jonathan Glenn has run inhaler specialist Consort since 2007 and previously held senior financial roles across the medical industry
UPDATE - Tissue Regenix completes enrolment process
The strict selection criteria meant that there was only a small pool of patients that could be considered
Tissue Regenix getting set to revolutionise knee surgery
Put simply, Tissue Regenix takes a tendon or cartilage – either from a human or from a pig – treats it and uses it to replace damaged tissue within the body.
Tissue Regenix one to watch next year, says Jefferies
Tissue has developed a skin graft product, a tendon replacement product as well as heart valves.
Investments and investor services
FTSE100 ends much lower after OPEC meeting
The FTSE100, which had been just slightly lower at lunch, eased further, ending the day at 6,228, a drop of 46 points
Investments and investor services
Proactive news highlights: Tissue Regenix, ReNeuron, DiamondCorp, Cairn Energy and more
Stratmin Global, Tertiary Minerals and Fastjet also had news out on Friday
Market: Anglo rises despite likely divi cut
The UK’s main index lost around 8 points to 6,266
FTSE 100 drifts lower on Draghi, OPEC and jobs
FTSE 100 dipped 10 points to 6,264, with similar–sized falls in France and Germany
Tissue Regenix kicks off tendon trial
ACL ruptures are the second most common knee injury with around 900,000 procedures a year performed in Europe and the US. The main surgical options for this type of injury are limited to taking tissue from the patient, human donor material